Actively Recruiting
Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)
Led by Sohag University · Updated on 2025-08-05
668
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this pragmatic, decentralized, pre-consented, event-driven, randomized controlled trial is to investigate the efficacy of add-on ketamine to second-dose midazolam for prehospital treatment of epileptic children with convulsive status epilepticus.
CONDITIONS
Official Title
Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 2 to 16 years.
- Established diagnosis of epilepsy of at least 1 year duration.
- History of at least 1 episode of convulsive status epilepticus in the preceding 12 months.
You will not qualify if you...
- Failure to obtain informed consent.
- Known allergies or contraindications to ketamine.
- Known contraindications to intramuscular injection.
- Presence of another family member included in the same trial.
- Having subsequent events (only the index event will be included).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Pediatrics at Sohag University Hospital
Sohag, Egypt, 82524
Actively Recruiting
Research Team
E
Elsayed Abdelkreem
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here